Sutimlimab
Sutimlimab is a novel monoclonal antibody targeting complement protein C1. Sutimlimab is commonly used as a C1 inhibitor to treat cold agglutina-associated hemolysis.
Product Specifications
CAS Number
2049079-64-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Complement System
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
R2031-38U-PE 100 µL
RPS6KB1, CT (Ribosomal Protein S6 Kinase beta-1, S6K-beta-1, S6K1, 70kD Ribosomal Protein S6 Kinase 1, P70S6K1, p70-S6K 1, p70 Ribosomal S6 Kinase alpha, p70 S6 Kinase alpha, p70 S6K-alpha, p70 S6KA, p70-S6K, Ribosomal Protein S6 Kinase I, Serine/threonine-protein Kinase 14A, STK14A) (PE) discontinued
Sign In for Pricing
View Details 
K4849002 1.0 µg DNA
Trim56 sgRNA CRISPR Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details